These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17092250)

  • 41. [Detection of minimal residual disease in leukemia using flow cytometry].
    Muroi K
    Rinsho Ketsueki; 2008 Jun; 49(6):397-407. PubMed ID: 18646607
    [No Abstract]   [Full Text] [Related]  

  • 42. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.
    Mussolin L; Pillon M; Conter V; Piglione M; Lo Nigro L; Pierani P; Micalizzi C; Buffardi S; Basso G; Zanesco L; Rosolen A
    J Clin Oncol; 2007 Nov; 25(33):5254-61. PubMed ID: 18024872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.
    Köstler WJ; Brodowicz T; Hejna M; Wiltschke C; Zielinski CC
    Cancer Detect Prev; 2000; 24(4):376-403. PubMed ID: 11059569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment.
    Björklund E; Matinlauri I; Tierens A; Axelsson S; Forestier E; Jacobsson S; Ahlberg AJ; Kauric G; Mäntymaa P; Osnes L; Penttilä TL; Marquart H; Savolainen ER; Siitonen S; Torikka K; Mazur J; Porwit A
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):406-15. PubMed ID: 19648789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detecting minimal residual disease in patients with chronic lymphocytic leukemia using 8-color flow cytometry protocol in routine hematological practice.
    Stehlíková O; Chovancová J; Tichý B; Krejčí M; Brychtová Y; Panovská A; Francová Skuhrová H; Burčková K; Borský M; Loja T; Mayer J; Pospíšilová S; Doubek M
    Int J Lab Hematol; 2014 Apr; 36(2):165-71. PubMed ID: 24028768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Detection of minimal residual leukemia using polymerase chain reaction method].
    Naoe T
    Rinsho Byori; 1996 Jun; 44(6):535-40. PubMed ID: 8752731
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simplified sensitive method for the detection of B-cell clonality in lymphoid malignancies.
    Jilani I; Keating M; Day A; William W; Kantarjian H; O'brien S; Giles FJ; Albitar M
    Clin Lab Haematol; 2006 Oct; 28(5):325-31. PubMed ID: 16999724
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Residual disease in acute lymphoblastic leukemia of childhood: methods of detection and clinical relevance.
    Faderl S; Estrov Z
    Cytokines Cell Mol Ther; 1998 Jun; 4(2):73-85. PubMed ID: 9681246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.
    Muzzafar T; Medeiros LJ; Wang SA; Brahmandam A; Thomas DA; Jorgensen JL
    Am J Clin Pathol; 2009 Nov; 132(5):692-8. PubMed ID: 19846809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring minimal residual disease in pediatric hematologic malignancies.
    Campana D
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):876-7, 915. PubMed ID: 18185484
    [No Abstract]   [Full Text] [Related]  

  • 51. Detection of early precursors of t(12;21) positive pediatric acute lymphoblastic leukemia during follow-up.
    László R; Alpár D; Kajtár B; Lacza A; Ottóffy G; Kiss C; Bartyik K; Nagy K; Pajor L
    Pediatr Blood Cancer; 2010 Jan; 54(1):158-60. PubMed ID: 19813247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Applications of cytometry to study acute leukemia: in vitro determination of drug sensitivity and detection of minimal residual disease.
    Campana D
    Cytometry; 1994 Jun; 18(2):68-74. PubMed ID: 7924700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flow cytometric cell sorting combined with molecular chimerism analysis to detect minimal recurrent leukemia: good news and bad news.
    Lamb LS; Robbins NF; Abhyankar S; Joyce M; Stetler-Stevenson M; Henslee-Downey PJ; Gee AP
    Bone Marrow Transplant; 1997 Jun; 19(11):1157-61. PubMed ID: 9193762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should the presence of minimal residual disease (MRD) in morphologic complete remission alter post-remission strategy in AML?
    Stone RM
    Best Pract Res Clin Haematol; 2011 Dec; 24(4):509-14. PubMed ID: 22127313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods.
    Zwick D; Cooley L; Hetherington M
    Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flow cytometric MRD detection in selected mature B-cell malignancies.
    Böttcher S; Ritgen M; Kneba M
    Methods Mol Biol; 2013; 971():149-74. PubMed ID: 23296963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry.
    Mejstríková E; Fronková E; Kalina T; Omelka M; Batinić D; Dubravcić K; Pospísilová K; Vásková M; Luria D; Cheng SH; Ng M; Leung Y; Kappelmayer J; Kiss F; Izraeli S; Stark B; Schrappe M; Trka J; Starý J; Hrusák O
    Pediatr Blood Cancer; 2010 Jan; 54(1):62-70. PubMed ID: 19760767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction.
    Yamazaki J; Baba K; Goto-Koshino Y; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):321-31. PubMed ID: 18977540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases.
    Cambier N; Soenen-Cornu V; Laï JL; Cosson A; Fenaux P; Preudhomme C
    Haematologica; 2000 Jun; 85(6):664-5. PubMed ID: 10870127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.